
David J. E. Callaway, PhD
The polymerization of the amyloid beta-peptide into
protease-resistant fibrils is a significant step in the
pathogenesis of Alzheimer's disease. Compounds
capable of interfering with the polymerization process
thus may lead to potent therapeutics. In order to
design such compounds, a detailed understanding of the
polymerization process at the molecular level is essential.
Conventional experimental techniques alone have lacked the
precision to yield this detail. Accordingly, we
employ a combination of biological, chemical, and physical
techniques to understand and combat fibril formation.
Professor and Laboratory Director
Learn about the lab
and
Looking for a job? Interested in trying to cure Alzheimer's disease?
Want to get a PhD? Want a summer internship?
Apply
Potential therapeutics for Alzheimer's disease
(PDF format)

Small-angle X-ray scattering (SAXS) with my MILLION DOLLAR BABY:

.


! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !